Orbimed Advisors - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 184 filers reported holding GW PHARMACEUTICALS PLC in Q1 2017. The put-call ratio across all filers is 1.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2018$3,628,000
+23.8%
21,0000.0%0.04%
+25.7%
Q2 2018$2,930,000
-64.9%
21,000
-71.6%
0.04%
-66.0%
Q1 2018$8,338,000
+42.3%
74,000
+66.7%
0.10%
+39.2%
Q4 2017$5,861,000
-89.7%
44,400
-92.1%
0.07%
-86.4%
Q3 2017$56,943,000
+1.2%
561,0710.0%0.54%
-7.8%
Q2 2017$56,247,000
-2.3%
561,071
+17.9%
0.59%
-9.5%
Q1 2017$57,555,000
+29.9%
475,900
+20.0%
0.65%
+15.4%
Q4 2016$44,320,000
+822.4%
396,600
+995.6%
0.56%
+927.3%
Q3 2016$4,805,000
-65.1%
36,200
-81.0%
0.06%
-62.1%
Q1 2016$13,752,000
-34.9%
190,600
-37.3%
0.14%
-24.1%
Q4 2015$21,117,000
-38.7%
304,100
-19.4%
0.19%
-45.1%
Q3 2015$34,456,000
-13.7%
377,100
+16.0%
0.35%
+18.8%
Q2 2015$39,923,000
+116.9%
325,000
+60.9%
0.29%
+86.6%
Q1 2015$18,408,000
+3.0%
202,000
-8.6%
0.16%
-16.0%
Q3 2014$17,868,000
+215.1%
221,000
+131.4%
0.19%
+167.1%
Q1 2014$5,670,000
-57.4%
95,500
-70.2%
0.07%
-64.1%
Q4 2013$13,301,000320,2000.20%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2017
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders